Thursday, August 6, 2026

Federal courts are consistently ruling against health insurers in disputes over the No Surprises Act's independent dispute resolution process. Judges are overturning IDR decisions that sided with payers, finding arbitrators improperly weighed insurer-negotiated rates over the qualifying payment amount. This trend signals increased judicial scrutiny of how payers are implementing the law's payment dispute mechanisms. Monitor these rulings; the legal momentum may strengthen provider negotiating positions in future out-of-network payment disputes, particularly for emergency and ancillary services.

Senators Tammy Baldwin and Jerry Moran introduced the 340B Program Integrity and Transparency Act. The bill aims to reform the drug discount program by imposing new reporting requirements on covered entities and manufacturers, clarifying patient and contract pharmacy definitions, and increasing oversight. It seeks to address years of litigation and payer pushback by establishing clearer program rules. The legislative text is not yet public, but the move indicates a serious congressional effort to stabilize the program after a decade of expansion and controversy. Track the bill's progress; final language will dictate new compliance obligations for hospitals and clinics participating in 340B.

CMS has proposed updates to remote physiologic monitoring and remote therapeutic monitoring codes in the 2027 Physician Fee Schedule. The changes aim to clarify billing requirements, potentially expanding coverage for AI-enhanced monitoring and streamlining technology integration. The agency is responding to rapid tech adoption and seeking to align reimbursement with contemporary care delivery models. The proposed rule is open for comment, with a final rule expected by November 1, 2026. Review the proposed RPM/RTM code descriptors and documentation requirements; practices heavily invested in chronic care management via digital tools may need to adjust workflows if the changes are finalized.

Local reporting from Indiana and Pennsylvania details the human impact of the federal Medicaid work requirement. In Indiana, families describe feeling 'powerless' as they lose coverage, with over 80,000 affected statewide. In Allegheny County, Pennsylvania, officials warn 26,000 residents could lose coverage under the same federal rules. This coverage churn will increase patient self-pay volume and administrative burden for frontline staff. The stories signal the operational reality that billing departments will face: more uninsured visits and complex retroactive eligibility checks as patients cycle on and off the program.

NBC News reports private insurers are increasingly denying coverage for GLP-1 weight-loss drugs like Wegovy and Zepbound after patients achieve target weight loss. This creates a 'post-stabilization cliff' where maintenance therapy is no longer covered. The denials hinge on payer interpretations of medical necessity and clinical guidelines for chronic weight management. This mid-course coverage change will trigger patient complaints and require new prior authorization battles for continuing therapy. Practices with a high-volume weight management service should brief clinical and billing staff on this emerging denial pattern and prepare patient-facing materials.